Head-to-head · Cost-Efficiency Index
Luvo Health vs GoodRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Luvo Health
Shoppers who want to read a complete, un-gated price list — compounded and brand, injection and tablet, at four commitment lengths — and who will do the four-week arithmetic before comparing it with a monthly rate.
Visit Luvo HealthGoodRx
Cost-first shoppers who want self-pay access to brand-name Zepbound without a compounded product.
Visit GoodRxThe verdict
GoodRx takes it, leading the Cost-Efficiency Index 56 to 54. GoodRx is a NASDAQ-listed prescription discount platform, not a prescriber. Luvo Health still earns a C — Shoppers who want to read a complete, un-gated price list — compounded and brand, injection and tablet, at four commitment lengths — and who will do the four-week arithmetic before comparing it with a monthly rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs GoodRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Luvo Health | GoodRx |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 56/100 |
| Semaglutide / mo | $249 per 4 weeks (injection, compounded) | Not disclosed |
| Tirzepatide / mo | $339 per 4 weeks (injection, compounded) | $299/mo (brand Zepbound, contract term) |
| Semaglutide / yr (modeled) | $2,988 | — |
| Tirzepatide / yr (modeled) | $4,068 | $3,588 |
| Coverage | Not published | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #318 | #323 |
Luvo Health
54/100Where the value is
- The whole price list is public and server-rendered at /pricing — 156 rows, every medication, both forms and all four commitment lengths — before any intake, quiz, login or email capture
- Both molecules and both routes are priced: semaglutide injection $249, semaglutide tablets $279 and tirzepatide injection $339 per 4 weeks, with no separate membership or visit line item on the price table
- Real brand-name access with real prices — Ozempic® $1,299 and Zepbound® $1,399 per 4 weeks — rather than a brand logo with no purchasable figure behind it
The tradeoffs
- Prices are billed every FOUR WEEKS, not monthly, so thirteen charges fall in a calendar year rather than twelve — this page's modeled 12-month figure is twelve four-week periods, which is 48 weeks, and the real annual cost is one period higher
- Two pages headline "Starting at $45/week", which is the 52-week prepay rate divided out — the weight-loss page discloses that it is billed annually and the medication page does not, so the same number is honest on one page and not on the other
GoodRx
56/100Where the value is
- Real FDA-approved brand medication, not compounded
- 70,000+ pharmacy redemption network under the Lilly self-pay partnership
- No membership fee — bring a prescription and use the card/program at the pharmacy counter
The tradeoffs
- Direct verification of goodrx.com was blocked in this research session (403 on every fetch) — the figure above is corroborated via indexed snippets and GoodRx's own press release, not a page personally read live; a follow-up direct check is advisable
- GoodRx is a discount/self-pay card, not a prescriber — a clinician visit is still required separately
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.